Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | BMC Cancer

Figure 3

From: ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma

Figure 3

ECRG4 promoter methylation in primary glioma tissue samples. COBRA analysis of ECRG4 methylation in astrocytic gliomas of different WHO grades and two non-neoplastic brain samples (NB1, NB2). Representative data from 49 samples are shown. Arrows point to restriction fragments indicating a methylated sequence. The diagnosis is given in the subheadings. The tumor numbers are provided on top of each lane.

Back to article page